Back to User profile » Dr Meng Wang
Papers published by Dr Meng Wang:
Overexpression of FAM234B Predicts Poor Prognosis in Patients with Luminal Breast Cancer
Lyu L, Wang M, Zheng Y, Tian T, Deng Y, Xu P, Lin S, Yang S, Zhou L, Hao Q, Wu Y, Dai Z, Kang H
Cancer Management and Research 2020, 12:12457-12471
Published Date: 3 December 2020
Therapeutic Effect of Doxorubicin-Chlorin E6-Loaded Mesoporous Silica Nanoparticles Combined with Ultrasound on Triple-Negative Breast Cancer
Xu P, Yao J, Li Z, Wang M, Zhou L, Zhong G, Zheng Y, Li N, Zhai Z, Yang S, Wu Y, Zhang D, Dai Z
International Journal of Nanomedicine 2020, 15:2659-2668
Published Date: 21 April 2020
Association Between Genetic Polymorphisms In TYMS And Glioma Risk In Chinese Patients: A Case-Control Study
Yao L, Zhou L, Deng Y, Zheng Y, Yang P, Wang M, Dong S, Hao Q, Xu P, Li N, Wu Y, Zhai Z, Lyu L, Dai Z
OncoTargets and Therapy 2019, 12:8241-8247
Published Date: 7 October 2019
Prognostic values of HE4 expression in patients with cancer: a meta-analysis
Dai C, Zheng Y, Li Y, Tian T, Wang M, Xu P, Deng Y, Hao Q, Wu Y, Zhai Z, Dai Z, Lyu J
Cancer Management and Research 2018, 10:4491-4500
Published Date: 10 October 2018
Pooling analysis on prognostic value of PHH3 expression in cancer patients
Hao Q, Dai C, Deng Y, Xu P, Tian T, Lin S, Wang M, Liu K, Song D, Wu Y, Guo Y, Dai Z
Cancer Management and Research 2018, 10:2279-2288
Published Date: 30 July 2018
CYP17 polymorphisms are associated with decreased risk of breast cancer in Chinese Han women: a case–control study
Yang P, Wang M, Tian T, Feng Y, Zheng Y, Yang T, Li H, Lin S, Xu P, Deng Y, Hao Q, Li N, Guan F, Dai Z
Cancer Management and Research 2018, 10:1791-1798
Published Date: 3 July 2018
Association of two FOXP3 polymorphisms with breast cancer susceptibility in Chinese Han women
Tian T, Wang M, Zheng Y, Yang T, Zhu W, Li H, Lin S, Liu K, Xu P, Deng Y, Zhou L, Dai Z
Cancer Management and Research 2018, 10:867-872
Published Date: 26 April 2018
Association between body mass index and breast cancer risk: evidence based on a dose–response meta-analysis
Liu K, Zhang W, Dai Z, Wang M, Tian T, Liu X, Kang H, Guan H, Zhang S, Dai Z
Cancer Management and Research 2018, 10:143-151
Published Date: 18 January 2018
Prognostic role and clinical significance of trophoblast cell surface antigen 2 in various carcinomas
Xu P, Zhao Y, Liu K, Lin S, Liu X, Wang M, Yang P, Tian T, Zhu Y, Dai Z
Cancer Management and Research 2017, 9:821-837
Published Date: 12 December 2017
Prognostic and predictive values of PD-L1 expression in patients with digestive system cancer: a meta-analysis
Dai C, Wang M, Lu J, Dai Z, Lin S, Yang P, Tian T, Liu X, Min WL, Dai Z
OncoTargets and Therapy 2017, 10:3625-3634
Published Date: 21 July 2017
Distinct role of the Fas rs1800682 and FasL rs763110 polymorphisms in determining the risk of breast cancer among Han Chinese women
Wang M, Wang Z, Wang XJ, Jin TB, Dai ZM, Kang HF, Guan HT, Ma XB, Liu XH, Dai ZJ
Drug Design, Development and Therapy 2016, 10:2359-2367
Published Date: 25 July 2016
PSCA rs2294008 C > T polymorphism contributes to gastric and bladder cancer risk
Wang M, Wang XJ, Ma YF, Ma XB, Dai ZM, Lv Y, Lin S, Liu XH, Yang PT, Dai ZJ
Therapeutics and Clinical Risk Management 2015, 11:237-245
Published Date: 13 February 2015
Association between MDM2 rs 2279744 polymorphism and breast cancer susceptibility: a meta-analysis based on 9,788 cases and 11,195 controls
Gao J, Kang AJ, Lin S, Dai ZJ, Zhang SQ, Liu D, Zhao Y, Yang PT, Wang M, Wang XJ
Therapeutics and Clinical Risk Management 2014, 10:269-277
Published Date: 15 April 2014